Singapore has emerged as a premier global hub for Biomedical Sciences. As a leading Allergy Relief Medicines Factory & Exporter, we leverage Singapore's strategic position at the crossroads of major shipping routes and its world-class regulatory environment overseen by the Health Sciences Authority (HSA).
The industrial landscape in Singapore for allergy relief is characterized by highly automated manufacturing lines and a rigorous commitment to PICS/GMP standards. This ensures that every batch of antihistamines or anti-inflammatory agents meets the stringent safety profiles required by both the local Singaporean market and international regulatory bodies in Europe and North America.
Our production utilizes AI-driven quality control systems to monitor API purity levels in real-time, ensuring zero-defect exports from our Singapore-aligned distribution networks.
Singapore's unique tropical climate, characterized by high humidity and consistent temperatures, presents a specific set of challenges for allergy sufferers. The prevalence of allergic rhinitis and atopic dermatitis is notably high in urbanized environments like Singapore, where dust mites, mold spores, and occasional haze pollution act as persistent triggers.
Providing rapid-acting antihistamines for Singaporean professionals facing pollen and dust-related congestion in high-density office environments.
With a booming pet ownership culture in districts like Tiong Bahru and Orchard, our feline and canine-specific allergy tablets (like Furosemide) are in high demand.
Supplying essential allergy relief kits for international shipping crews docking at the Port of Singapore Authority (PSA).
The pharmaceutical industry in Singapore is currently shifting towards Personalized Allergy Management. We are seeing a transition from broad-spectrum antihistamines to targeted therapy using pure API powders like Desloratadine and Diphenhydramine HCl. These raw materials allow for compounding pharmacies to create tailored dosages for sensitive populations, including pediatrics and geriatrics.
Furthermore, there is a significant push towards Sustainability in Pharma. Our factories are integrating green chemistry principles, reducing the carbon footprint of chemical synthesis for APIs. This aligns with the "Singapore Green Plan 2030," ensuring that our exports are not only effective but also environmentally responsible.
Xian QLU Health Pharmaceutical Technology Co., Ltd. is a powerhouse in the development, production, and marketing of pharmaceutical products, food ingredients, vitamins, intermediates, and high-purity chemicals.
While headquartered in Xian, China, we operate as a vital exporter to the Singapore market, utilizing our 3 strategic production bases in Shandong, Zhejiang, and Hebei. Our facilities are prestigious holders of GMP, ISO, FAMI-QS, KOSHER, and HALAL certifications.
Our commitment to excellence ensures that we have complete control over product development and design, utilizing advanced inspection facilities that mirror the high technological standards found in Singapore’s Tuas Biomedical Park.
With strategic marketing partners in Mumbai and Dubai, and a specialized focus on the Southeast Asian corridor via Singapore, Richer Pharma (QLU) is uniquely positioned to bridge the gap between high-volume production and local distribution needs.
"In the ever-changing pharmaceutical industry, the spirit of QLU is characterized by flexibility and adaptability. We embrace emerging technologies and adopt new scientific advancements to meet the needs of patients worldwide."
Established focus on core pharmaceutical products, food ingredients, and vitamins.
Expansion into the global marketing of APIs and chemical intermediates.
Integrated full-scale production and marketing ecosystem for international compliance.
Devoted to hyper-advanced development of specialized APIs for global export hubs like Singapore.
As a specialized Allergy Relief Medicines Factory, we understand that the Singaporean market demands high efficacy and rapid bioavailability. Our Desloratadine and Diphenhydramine series are processed using micronization technology to ensure faster absorption rates, which is critical for acute allergic reactions common in the tropics.
QLU Health
